Additionally, evaluation of serum AFP level and albumin-bilirubin (ALBI) grade, along with liver cirrhosis, tumor margin, and radiomics signatures have increased ML-based contrast-enhanced CT performance accuracy in the prediction of HCC recurrence rate after curative tumor resection [57]. The gene discussed is AFP; the disease is hepatocellular carcinoma.